FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Gly topics
Door Assembly
Swimming Goggles
Transverse
Alkoxylate
Fluoropolymer
Air Cleaning
Rotor Shaft
Aspect Ratio
Disconnect
Synchronization
Remote Control
Ethylene Glycol
Surfactant
Combustion
Steviol Glycosides

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Gly patents



      
           
This page is updated frequently with new Gly-related patent applications. Subscribe to the Gly RSS feed to automatically get the update: related Gly RSS feeds. RSS updates for this page: Gly RSS RSS


Triterpene glycoside and triterpene compositions and methods of using same

Date/App# patent app List of recent Gly-related patents
07/17/14
20140200373
 Formate based heat stable salt mitigation in physical solvent acid gas absorption processes patent thumbnailnew patent Formate based heat stable salt mitigation in physical solvent acid gas absorption processes
There is described a process for reducing the concentration of formate based heat stable salts formed in a physical solvent acid gas absorption process (12) wherein acid gas contaminants such as hydrogen sulfide and carbon dioxide are removed from gas mixtures (30) which include these contaminants. The process comprises the step of contacting the physical solvent containing formate based heat stable salts (46) with a metallic and/or organometallic catalyst (52), preferably the catalyst comprises palladium, zinc, platinum, nickel, or rhodium, and/or salts thereof and/or oxides thereof.
07/17/14
20140200342
 Process for preparing 3'-thiosubstituted cephalosporins employing a pencillin g acylase patent thumbnailnew patent Process for preparing 3'-thiosubstituted cephalosporins employing a pencillin g acylase
The present invention relates to a process for the preparation of 3′-thiosubstituted cephalosporins by enzymatic condensation of a nucleus with a phenylglycine derivative. Furthermore the present invention relates to a crystalline form of a compound of general formula (1) wherein r2 is oh and x is s and r1 is a radical of formula (2a) with r3 is ch3..
07/17/14
20140200330
 Isolation of phosphoproteins, glycoproteins and fragments thereof patent thumbnailnew patent Isolation of phosphoproteins, glycoproteins and fragments thereof
The invention provides methods and apparatus for the selective isolation of phosphorylated and glycosylated proteins and their fragments. A lanthanide metal cation is used to precipitate proteins or protein fragments containing phospho groups and/or glyco groups.
07/17/14
20140200267
 Second generation fatty acid compositions, formulations, and methods of use and synthesis thereof patent thumbnailnew patent Second generation fatty acid compositions, formulations, and methods of use and synthesis thereof
An orally administered fatty acid composition for the treatment of cardiovascular diseases, and a method of treating same, are provided. The compound includes 5z,8z,11z,14z,17z-eicosapentaenoic ethanolamide (epa ethanolamide), 4z,7z,10z,13z,16z,19z-docosahexaenoic ethanolamide (dha ethanolamide), and at least one tocotrienol.
07/17/14
20140200257
 Pegylated lipids and their use for drug delivery patent thumbnailnew patent Pegylated lipids and their use for drug delivery
The invention provides poly(ethylene glycol)-lipid conjugates for use in drug delivery.. .
07/17/14
20140200180
 Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens patent thumbnailnew patent Method for producing proteins in pichia pastoris that lack detectable cross binding activity to antibodies against host cell antigens
Methods for producing proteins and glycoproteins in pichia pastoris that lack detectable cross binding activity to antibodies made against host cell antigens are described. In particular, methods are described wherein recombinant pichia pastoris strains that do not display a β-mannosyltransferase 2 activity with respect to an n-glycan or o-glycan and do not display at least one activity selected from a β-mannosyltransferase 1, 3, and 4 activity to produce recombinant proteins and glycoproteins.
07/17/14
20140200178
 Method of detection of clinically significant post-prandial hyperglycemia in normoglycemic patients patent thumbnailnew patent Method of detection of clinically significant post-prandial hyperglycemia in normoglycemic patients
This invention relates to a method for detecting the presence of or likelihood of a patient of developing occult pancreatic beta cell dysfunction, and a method for detecting the presence of or likelihood of a patient of developing clinically significant post-prandial hyperglycemia. The methods involve (a) measuring a level of alpha-hydroxybutyrate (ahb) in a single fasting baseline biological sample of the patient; (b) comparing the level of ahb in the single fasting baseline biological sample to a reference ahb level; and (c) determining the presence of or likelihood of developing the disorder in the patient based on the comparison in step (b).
07/17/14
20140200177
 Method of detection of occult pancreatic beta cell dysfunction in normoglycemic patients patent thumbnailnew patent Method of detection of occult pancreatic beta cell dysfunction in normoglycemic patients
This invention relates to a method for detecting the presence of or likelihood of a patient of developing occult pancreatic beta cell dysfunction, and a method for detecting the presence of or likelihood of a patient of developing clinically significant post-prandial hyperglycemia. The methods involve (a) measuring a level of alpha-hydroxybutyrate (ahb) in a single fasting baseline biological sample of the patient; (b) comparing the level of ahb in the single fasting baseline biological sample to a reference ahb level; and (c) determining the presence of or likelihood of developing the disorder in the patient based on the comparison in step (b).
07/17/14
20140200148
 Apparatuses, methods, computer program products, and kits for hi-throughput glycan analysis patent thumbnailnew patent Apparatuses, methods, computer program products, and kits for hi-throughput glycan analysis
An apparatus for glycan analysis is disclosed. The apparatus includes a plurality of loading wells adapted to receive a plurality of samples; a plurality of capillaries arranged in correspondence with the loading wells, each of the capillaries including a first portion including a stacking gel and a second portion including a resolving gel; and a plurality of eluting wells arranged in correspondence with the capillaries and adapted to receive a portion of the samples having traversed the capillaries..
07/17/14
20140199750
 Monofunctional branched polyethylene glycol and modified bio-related substance thereof patent thumbnailnew patent Monofunctional branched polyethylene glycol and modified bio-related substance thereof
The monofunctional branched poly(ethylene glycol) (peg) has a general formula shown in formula (1), and the bio-related substance modified by the monofunctional branched peg has a general fomula shown in formula (2), wherein x1 and x2 are each independently a hydrocarbon group having 1 to 20 carbon atoms, n1 and n2 are each independently an integer selected from 1 to 1000, n3 is an integer selected from 11 to 1000, l1, l2 are each independently a linking group, p is 0 or 1, q is 0 or 1, r1 is a hydrogen atom or a hydrocarbon group having 1 to 20 carbon atoms, d is a bio-related substance, z is a linking group, and z can react with the bio-related substance to form a residue group l3. The peg-modified bio-related substance maintains good biological activity, and has better solubility and a longer half-life in vivo..
07/17/14
20140199733
new patent Method for producing gamma-cyclodextrin by simultaneous use of gamma-cyclodextrin glycosyltransferase and isoamylase
The present invention provides a method for the production of γ-cd, comprising making a starch slurry, incubating with γ-cgtase and isoamylase simultaneously for γ-cd production, forming a complex of γ-cd and an organic complexant, and purifying γ-cd from the complexant. The present invention provides a simple and cost-effective method for producing high purity γ-cd, which has a short production cycle, a high conversion rate, and is adaptable to large-scale industrial production..
07/17/14
20140199416
new patent Mold and mildew stain removing solution
A solution having improved mold and mildew stain removing properties on hard surfaces, that is easier to handle (less corrosive and less malodorous) and that is environmentally friendly. The mold and mildew stain removing solution includes the following components: a surfactant selected from the group consisting of alcohol ethoxylates, alkyl sulfates, alkyl ether sulfates, alpha olefin sulfonates, alkyl phosphates, alkyl amidopropyl betaines, alkyl betaines, amphoacetates, amphoproprionates, amphosulfonates, amine oxides, alkanolamides, sulfosuccinates, and sultaines, a solvent, and at least one chelating agent.
07/17/14
20140199297
new patent Triterpene glycoside and triterpene compositions and methods of using same
In the present invention, different strategies are used to improve the bioavailability of triterpene glycosides and triterpenes including, for example, (a) a covalent approach involving modification with polyethylene glycol and (b) a formulation approach involving non-covalent encapsulation in antibody targeted pol(dl-lactic acid) nanoparticles.. .
07/17/14
20140199282
new patent Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof
Provided are soluble neutral active hyaluronidase glycoproteins (shasegp's), methods of manufacture, and their use to facilitate administration of other molecules or to alleviate glycosaminoglycan associated pathologies. Minimally active polypeptide domains of the soluble, neutral active shasegp domains are described that include asparagine-linked sugar moieties required for a functional neutral active hyaluronidase domain.
07/17/14
20140199270
new patent Methods and compositions to reduce fat gain, promote weight loss in mammals
The present disclosure relates to compositions and related methods to reduce body weight, body fat, waist and hip size, plasma total cholesterol, ldl, triglycerides, blood glucose, leptin and c-reactive protein levels and increase in hdl and serotonin levels in an mammal. The lepticore® formulation disclosed, at both the low and high dosages, is helpful in the management of fat gain and its related complications.
07/17/14
20140199257
new patent Composition for reducing toilet odor containing polypropylene glycol as a reactive gas barrier
A method and composition is provided that aids in the reduction of objectionable volatile odors when a few drops are placed in the toilet prior to use. In one embodiment, the composition contains a high molecular weight polypropylene glycol (ppg) together with a dispersing agent to create an instantaneous multifunctional surface barrier of the polypropylene glycol/isopropanol mixture across the water surface.
07/17/14
20140199246
new patent Stevia composition
Stevia compositions are prepared from steviol glycosides of stevia rebaudiana bertoni. The compositions are able to provide a superior taste profile and can be used as sweetness enhancers, flavor enhancers and sweeteners in foods, beverages, cosmetics and pharmaceuticals..
07/17/14
20140197580
new patent Method for producing a bio-pet polymer
The invention relates to a method for producing a bio-pet polymer comprising the following steps: step a) providing at least one diacid compound, comprising a terephtalate compound; step b) providing at least one diol compound, comprising monoethylene glycol; wherein—at least one of the terephtalate compound and/or the monoethylene glycol is obtained from at least one bio-based material, and—at least one of the diacid compound and/or the diol compound further comprises at least one crystallization retarding compound; and step c) copolymerizing a mixture of the diacid compound and the diol compound to obtain a bio-pet polymer comprising diacid units and diol units, comprising up to 7.5 mol % of unit(s) corresponding to the at least one crystallization retarding compound, based on the total number of moles of diacid units contained in the bio-pet. The invention also relates to a method for producing a bio-pet packaging element, comprising the following steps:—performing the method described above; and—step d) converting the bio-pet into the bio-pet packaging element..
07/17/14
20140196358
new patent Glycerol containing fuel mixture for direct injection engines
The invention provides fuel mixtures containing fuel oil, glycerol, glycerol impurities and non-ionic surfactants. The mixtures remain homogeneous longer and are more chemically stable than previous mixtures.
07/10/14
20140196177
Acyl-coa: diacylglycerol acyltransferase 1-like gene (ptdgat1) and uses thereof
An isolated protein which is at least partially encoded by a polynucleotide sequence encoding a novel acyl-coa: diacylglycerol acyltransferase 1—like gene (ptdgat1) from the diatom phaeodactylum tricomutum is provided together with a composition which includes the isolated protein and a transgenic organism transformed by a polynucleotide encoding same. The invention also provides a method for producing or enhancing the production of oil or triacylglycerols with high saturated fatty acids content..
07/10/14
20140194804
Chronic access system for extracorporeal treatment of blood including a continuously wearable hemodialyzer
A patient wearable, continuously operating extracorporeal pump apparatus which accesses the patient's arterial venous pressure differential by applying external pressure to a subcutaneous graft that has been cannualized to modulate blood flow through an extracorporeal circuit and to drive the pump for delivering a medicament, such as an anticoagulant, to the site of an intravenous cannula to prevent clogging thereof and also to move a dialysate through a circuit, including a dialyzer and a dialysate rejuvenating cartridge, whereby kidney failure can be treated without recourse to prior art hemodialysis machines found in most treatment facilities. With slight modification, the present invention can be used to remove excess fluids from chf patients, to remove toxins from the blood in those suffering from liver failure and to facilitate administration of insulin to diabetics and/or glucose to those having hypoglycemia..
07/10/14
20140194635
Production of biodiesel and glycerin from high free fatty acid feedstocks
A system and method for the conversion of free fatty acids to glycerides and the subsequent conversion of glycerides to glycerin and biodiesel includes the transesterification of a glyceride stream with an alcohol. The fatty acid alkyl esters are separated from the glycerin to produce a first liquid phase containing a fatty acid alkyl ester rich (concentrated) stream and a second liquid phase containing a glycerin rich (concentrated) stream.
07/10/14
20140194634
Method for preparing high purity biodiesel
Disclosed is a method for preparing high purity biodiesel from crude oils. The method comprises the steps of: pre-treating the crude oil raw material to remove impurities; pre-esterifying the pre-treated crude oil raw material under the effect of a catalyst of concentrated sulfuric acid; and then carrying out an ester exchange reaction in the presence of an alkali catalyst; recycling methanol, and separating glycerol, so as to obtain a crude fatty acid methyl ester; and subjecting the obtained fatty acid methyl ester to purification, distillation and segmentation to obtain a high-purity fatty acid methyl ester..
07/10/14
20140194567
Interpenetrating polymer networks derived from silylated triglyceride oils and polysiloxanes
A composition of matter comprising an interpenetrating polymer network of a combination of a silanol-containing polysiloxane phase and a silylated triglyceride oil phase. The two phases are mixed and covalently bound to each other via siloxane crosslinks.
07/10/14
20140194538
Defoamer for fermentation
Provided is a defoamer for fermentation which has excellent dispersibility in water and forms neither a precipitate nor oil droplets when the dispersion is heated, and which is highly effective in defoaming fermentation media. This defoamer contains a reaction product obtained by mixing a fat or oil having an iodine value of 40 to 130 with glycerin or like in a molar ratio of from 3/2 to 1/2 to obtain a mixture, causing 4 to 17 mol of propylene oxide to add to 1 mol of the mixture, and then causing 20 to 40 mol of ethylene oxide and 70 to 110 mol of propylene oxide to block-wise add thereto in this order, the reaction product having an ethylene oxide/propylene oxide molar ratio of from 1/4 to 2/5..
07/10/14
20140194536
Low-viscosity liquid crystal compound
Wherein x and y each denotes a hydrogen atom or together denote an oxygen atom, n denotes an integer from 0 to 2, m denotes the integer 1 or 2, and r denotes a hydrophilic group generated by removal of one hydroxyl group from any one selected from the group consisting of glycerol, erythritol, pentaerythritol, diglycerol, triglycerol, xylose, sorbitol, ascorbic acid, glucose, galactose, mannose, dipentaerythritol, maltose, mannitol, and xylitol; as well as a base for injection formulations and depot formulation comprising the same.. .
07/10/14
20140194532
Organopolysiloxane elastomer modified with mono-/diglycerin derivative, and use therefor
A crosslinked three-dimensional net-like structure having a carbon-silicon bond in a crosslinking part.. .
07/10/14
20140194509
Hydroxybutyrate ester and medical use thereof
A compound which is 3-hydroxybutyl 3-hydroxybutyrate enantiomerically enriched with respect to (3r)-hydroxybutyl (3r)-hydroxybutyrate of formula (i) is an effective and palatable precursor to the ketone body (3r)-hydroxybutyrate and may therefore be used to treat a condition which is caused by, exacerbated by or associated with elevated plasma levels of free fatty acids in a human or animal subject, for instance a condition where weight loss or weight gain is implicated, or to promote alertness or improve cognitive function, or to treat, prevent or reduce the effects of neurodegeneration, free radical toxicity, hypoxic conditions or hyperglycaemia.. .
07/10/14
20140194506
Use of potassium piperonyl pentadienoate for lowering blood lipid
The invention provides the use of potassium piperonyl pentadienoate for lowering blood lipid, including the use of the potassium piperonyl pentadienoate in the preparation of medicaments and health-care products for lowering serum total cholesterol, lowering low density lipoprotein cholesterol, lowering triglyceride as well as preventing the decrease of high density lipoprotein cholesterol.. .
07/10/14
20140194378
Methods of preventing or treating diseases and conditions using complex carbohydrates
The invention relates to a method of preventing and treating diseases and conditions associated with allergies, autoimmunity, the adhesion cascade, the metastatic cascade or the coronary cascade comprising administering (i) at least one complex carbohydrate as the sole active ingredient, or (ii) at least one pharmaceutical composition which comprises as an active ingredient a pharmacologically effective amount of at least one low purity or cosmetic grade complex carbohydrate selected from the group consisting of oligosaccharides, sialylated oligosaccharides, polysaccharides and glycosaminoglycans, and an effective amount of at least one transdermal or transmucosal carrier in an amount effective to deliver the complex carbohydrate into the blood stream.. .
07/10/14
20140194374
Anthelmintic formulations and treatments
A new method of controlling worm burden in ruminants by using two different injectable anthelmintics at or about the same time to increase the time between treatments and to rely on the animal's immune response. One of the anthelmintics is a long acting formulation capable of providing a sustained release of abamectin or other macrocyclic lactone for 2-14 days, to enable the anthelmintic to remove or kill incoming larvae for a sufficiently long period of time to allow the host to recognise the incoming larvae as foreign, and thus allow the ruminant to mount an immune response against these incoming larvae.
07/10/14
20140194367
Agrocybe aegerita lectin aal-2, and encoding gene thereof, preparation method therefor and application thereof
The isolated agrocybe aegerita lectin aal-2 is able to inhibit the growth of tumor cells by inducing apoptosis. In the animal study, the agrocybe aegerita lectin aal-2 has been showed to be capable for tumor therapy.
07/10/14
20140194352
Compositions and methods for treatment of metabolic disorders and diseases
The invention relates to variants and fusions of fibroblast growth factor 19 (fgf19), variants and fusions of fibroblast growth factor 21 (fgf21), fusions of fibroblast growth factor 19 (fgf19) and/or fibroblast growth factor 21 (fgf21), and variants or fusions of fibroblast growth factor 19 (fgf19) and/or fibroblast growth factor 21 (fgf21) proteins and peptide sequences (and peptidomimetics), having one or more activities, such as glucose lowering activity, and methods for and uses in treatment of hyperglycemia and other disorders.. .
07/10/14
20140194332
Two-phase lubricating oil composition
Lubricating oil compositions are provided herein that comprise a mixture of: (a) a hydrocarbon as a low-viscosity constituent, (b) a polyalkylene glycol (pag) as a high-viscosity constituent wherein the oxygen/carbon weight ratio is in the range of from 0.450 to 0.580, and (c) a compound as a control constituent wherein the oxygen/carbon weight ratio is in the range of from 0.080 to 0.350. Methods of lubricating a surface using such lubricating compositions are also provided herein..
07/10/14
20140193916
Electrotransformation of clostridium pasteurianum
By this invention, for the first time, a method for high-efficiency genetic transformation of the anaerobic bacterium clostridium pasteurianum is provided. Clostridium pasteurianum is a bacterium of substantial industrial importance, due to its selectivity and high productivity of the biofuel and biochemical n-butanol, and its ability to grow on a wide variety of inexpensive substrates.
07/10/14
20140193835
Cell-based detection of apf through its interaction with ckap4 for diagnosis of interstitial cystitis
An assay system designed to detect a protein biomarker in urine that is diagnostic for interstitial cystitis (ic). The presence of a 9 amino acid glycopeptide, antiproliferative factor (apf), in urine is unique to patients with ic.
07/10/14
20140193832
Detection of prostate cancer using psa glycosylation patterns
The present invention features novel methods for determining if a subject has prostate cancer. The present invention is based on the development of lectin immunosorbant assays which analyze α2,6-linked sialylation of total serum psa by sambucus nigra lectin (sna) and α2,3-linked sialylation of total and free serum psa.
07/10/14
20140193648
Biaxially stretched polyester film and method for producing same
A biaxially stretched polyester film, being a biaxially stretched film including a modified polybutylene terephthalate (modified pbt) and polyethylene terephthalate (pet), wherein a mass ratio (modified pbt/pet) between the modified pbt and pet is 20/80 to 5/95, the modified pbt is a pbt containing 5 to 20% by mass of a polytetramethylene glycol unit having a molecular weight of 600 to 4,000, the amount of tetrahydrofuran (thf) generated by heat treating the biaxially stretched film in a helium gas atmosphere at 180° c. For 30 minutes is 50 μg/g or less, and the biaxially stretched film has tear linearity in a lengthwise direction thereof..
07/10/14
20140193567
Hard butter
(2) 55 mass % or less of a total content of saturated fatty acids having 16 and 18 carbon atoms in constituent fatty acids of the diacylglycerols.. .
07/10/14
20140193562
Propylene glycol-free spray-dried compositions and methods of producing the same
The present invention relates to stable, propylene glycol-free and glycerin-free, spray-dried compositions containing flavors and optional surfactants for use in optically clear, liquid beverages and liquid beverage concentrates.. .
07/10/14
20140193387
Methods of reducing extravasation of inflammatory cells
A method for modifying access of cells to extravascular spaces and regions comprising administering to a patient an enzyme that cleaves chondroitin sulfate proteoglycans is provided. It has been found that administration of an enzyme that cleaves chondroitin sulfate proteoglycans to a patient disrupts extravasation of cells from the blood stream into tissue.
07/10/14
20140193383
Use of lactobacillus kefiranofaciens as a probiotic and a synbiotic
In accordance with the present invention, there is provided a probiotic composition comprising an effective amount of lactobacillus kefiranofaciens in association with a suitable carrier. The probiotic composition has many probiotic effects such as intestinal adherence, intestinal persistence, positive modulation of the intestinal microflora, protection against intestinal pathogens, immunomodulation, protection against systemic inflammation, protection against intestinal inflammation, protection against allergies, protection against diarrhea, protection against diabetes, protection against hyperlipidemia and protection against colon cancer.
07/10/14
20140193302
Base material comprising hydrophilic layer
This invention provides a base material comprising a plastic-containing support and, on its surface, a hydrophilic layer comprising an ethylene glycol chain (an eg chain) composed of one or more ethylene glycol units, as well as a method for producing such base material. A polysiloxane-containing primer layer is provided on the support comprising a plastic material on its surface, and the eg chain is covalently bound to a polysiloxane side chain of the primer layer.
07/10/14
20140190870
Synergistic h2s scavenger combination of transition metal salts with water-soluble aldehydes and aldehyde precursors
The use of a composition including a transition metal salt and at least one water-soluble aldehyde or water-soluble aldehyde precursor scavenges h2s that is present in aqueous fluids (e.g. Produced water liquid streams), natural gas and in oil and mixtures thereof (e.g.
07/10/14
20140190685
Downhole tools having non-toxic degradable elements and methods of using the same
Downhole tools for use in oil and gas production which degrade into non-toxic materials, a method of making them and methods of using them. A frac ball and a bridge plug comprised of polyglycolic acid which can be used in fracking a well and then left in the well bore to predictably, quickly, and safely disintegrate into environmentally friendly products without needing to be milled out or retrieved..
07/10/14
20140190644
Additives with cloud points to improve efficiency of release agents
This disclosure relates to papermaking and the use of creping adhesive and release agent compositions used in papermaking. In one aspect, there is provided a new class of release agents and compositions comprising release agents, the release agent comprising: a) a release agent comprising a quaternary imidazoline compound, an imidazoline free base, an oil-based dispersion, or a combination thereof; and b) a polyether component selected from a polypropylene glycol (ppg), a co-polymer of propylene glycol and ethylene glycol (co-ppg-peg), a blend of polypropylene glycol (ppg) and polyethylene glycol (peg), and a combination thereof, wherein the release composition has a cloud point in water at standard pressure from about 1° c.
07/10/14
20140190367
Galactose-rich polysaccharide, process for the production of the polymer and its applications
This invention concerns a biopolymer consisting of a polysaccharide composed of galactose (50-90%), glucose (1-25%), mannose (1-25%) and rhamnose (0.5-20%), which may additionally contain, in trace amounts, xylose, fucose, ribose, arabinose and/or fructose. The galactose-rich polymer also contains non-saccharide components, namely, acyl groups.


Popular terms: [SEARCH]

Gly topics: Door Assembly, Swimming Goggles, Transverse, Alkoxylate, Fluoropolymer, Air Cleaning, Rotor Shaft, Aspect Ratio, Disconnect, Synchronization, Remote Control, Ethylene Glycol, Surfactant, Combustion, Steviol Glycosides

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Gly for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gly with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.3302

3370

449492 - 0 - 71